Floatz logo

Therapeutic Allogeneic Lymphocytes

Testicular Choriocarcinoma and Embryonal Carcinoma

National Cancer Institute (NCI)Cell therapyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Testicular Choriocarcinoma and Embryonal Carcinoma cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
City of Hope Medical Center
Phase 2BBB
Carboplatin
City of Hope Medical Center
Phase 2BBB
FILGRASTIM
University of Southampton
Phase 2BBB
Ifosfamide
City of Hope Medical Center
Phase 2BBB
Busulphan
Northwestern University
Phase 2BB

View all 48 →

Same molecule, other indications

Therapeutic Allogeneic Lymphocytes is also rated in:

chronic myeloid leukemiaDormant
BBB
Indicative ·
72 / 100
View asset →
Relapsing Chronic Myelogenous LeukemiaDormant
BBB
Indicative ·
72 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →